Trial intelligence / Profile preview

Pilot urodynamic study of modified release UK-369,003 in men with lower urinary tract symptoms

2006-004380-58Phase 2Completed

Sponsor
Pfizer
Start
Dec 2006
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in Micturition disorder comparing Sequence starting with UK-369,003 with Sequence starting with placebo (2 arms). Primary endpoint: Urodynamic parameters assessing treatment efficacy. Started Dec 2006; status: completed.

02

Drugs

gisadenafil
03

Conditions

Micturition disorder

Beyond the preview

Go deeper on 2006-004380-58.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004380-58.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call